Table 3.
Economic Model Assumptions
Section of Model | Assumption | Source |
---|---|---|
Failure rate of first-line ATD | Approximately 5% of patients will fail to achieve remission with ATD during first-line therapy, requiring an alternative therapy | Expert opinion |
ATDs including PTU | Have similar effectiveness, side effect profile and cost | Expert opinion |
Choice of therapy after failure of first dose of RAI | Further doses of RAI given, rather than switching to other therapy. | Most common practice in Ethiopia |
Side effect of ATD and RAI | Does not have significant cost implications and not considered. | [11] |
Hypothyroidism after RAI and ATDs | Hypothyroidism is considered as treatment success along with Euthyroidism. | [12,13] |